About
Gene Therapy
Areas of Focus
Categories
Virus TechnologyGene Therapy, RNA & Peptide TherapyStem Cell & Cellular Therapy
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
48
By Phase
PHASE1/PHASE2: 3
By Status
RECRUITING: 2TERMINATED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06716853Lead Sponsor
A Clinical Gene Therapy Study with Hematopoietic Stem Cells for the Treatment, with Single Dose of Temferon, of Patients Suffering from Metastatic Renal Cell Carcinoma
PHASE1/PHASE2Recruiting
12 participants
Started: Oct 22, 2024 · Completed: Sep 30, 2026
NCT03875495Lead Sponsor
A Phase I/II Study Evaluating Temferon in Multiple Myeloma Patients With Early Relapse After Front Line Therapy (TEM-MM)
PHASE1/PHASE2Terminated
9 participants
Started: Mar 6, 2019 · Completed: Apr 2, 2021
NCT03866109Lead Sponsor
A Study Evaluating Temferon in Patients with Glioblastoma & Unmethylated MGMT
PHASE1/PHASE2Recruiting
27 participants
Started: Mar 5, 2019 · Completed: Dec 9, 2025
Locations (1)
Headquarters
Milan, Italy
Map
Loading map...